cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Gritstone Oncology Inc
7 own
7 watching
Current Price
$3.26
$-0.07
(-2.1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
238.42M
52-Week High
52-Week High
6.1
52-Week Low
52-Week Low
1.71
Average Volume
Average Volume
0.9M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization238.42M
icon52-Week High6.1
icon52-Week Low1.71
iconAverage Volume0.9M
iconDividend Yield--
iconP/E Ratio--
What does the Gritstone Oncology Inc do?
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Read More
How much money does Gritstone Oncology Inc make?
News & Events about Gritstone Oncology Inc.
Globe Newswire
2 months ago
Matthew Hawryluk, Ph.D. POAI Board of Directors EAGAN, Minn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Matthew J. Hawryluk, Ph.D., (www.predictive-oncology.com) to its Board of Directors to help support the companys ...
Globe Newswire
3 months ago
-- Median overall survival (OS) for patients with metastatic, microsatellite stable colorectal cancer (MSS-CRC) who had two prior lines of therapy and had molecular response will now exceed 22 months median not yet reached -- -- Patients who achieve a molecular response include those with liver ...
Globe Newswire
7 months ago
EMERYVILLE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the worlds most potent vaccines, today announced that the companys Board of Directors has granted eight employees nonqualified stock options to ...
Globe Newswire
8 months ago
-- Results, which were previously pre-printed in bioRxiv, show Gritstones second-generation self-amplifying mRNA (samRNA) vaccine candidate drove broad neutralizing antibodies, T cell responses and offered protection against SARS-CoV-2 infection in rhesus macaques -- -- Neutralizing antibody ...
Globe Newswire
8 months ago
EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the worlds most potent vaccines, today announced that the company has been certified as a Great Place to Work by the Great Place to Work Institute. ...
Frequently Asked Questions
Frequently Asked Questions
What is Gritstone Oncology Inc share price today?
plus_minus_icon
Can Indians buy Gritstone Oncology Inc shares?
plus_minus_icon
How can I buy Gritstone Oncology Inc shares from India?
plus_minus_icon
Can Fractional shares of Gritstone Oncology Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Gritstone Oncology Inc stocks?
plus_minus_icon
What is today’s traded volume of Gritstone Oncology Inc?
plus_minus_icon
What is today’s market capitalisation of Gritstone Oncology Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Gritstone Oncology Inc?
plus_minus_icon
What percentage is Gritstone Oncology Inc down from its 52-Week High?
plus_minus_icon
What percentage is Gritstone Oncology Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.26
$-0.07
(-2.1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00